MD Anderson's Department of Symptom Research is at the forefront of discovering new ways of identifying the symptoms and neurotoxicities associated with cancer and its treatment, the mechanisms underlying such symptoms and toxicities, and interventions that might reduce symptom severity or prevent symptom occurrence altogether. The department also advocates for policy change, awareness on the part of funding agencies, and broad inclusion of patient report in clinical studies, especially drug development trials. Because symptoms are subjective experiences, we believe that only the patient can truly know the severity, temporal pattern, quality, location and impact on activities and daily life that symptoms have - and that the patient's voice must therefore be heard.
<<Volver a la información del trabajo